204 related articles for article (PubMed ID: 18334745)
1. A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized spores.
Wild MA; Kumor K; Nolan MJ; Lockman H; Bowdish KS
Hum Antibodies; 2007; 16(3-4):99-105. PubMed ID: 18334745
[TBL] [Abstract][Full Text] [Related]
2. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
Chawla A; Midha S; Bhatnagar R
Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization against anthrax.
Galloway D; Liner A; Legutki J; Mateczun A; Barnewall R; Estep J
Vaccine; 2004 Apr; 22(13-14):1604-8. PubMed ID: 15068841
[TBL] [Abstract][Full Text] [Related]
5. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
Hepler RW; Kelly R; McNeely TB; Fan H; Losada MC; George HA; Woods A; Cope LD; Bansal A; Cook JC; Zang G; Cohen SL; Wei X; Keller PM; Leffel E; Joyce JG; Pitt L; Schultz LD; Jansen KU; Kurtz M
Vaccine; 2006 Mar; 24(10):1501-14. PubMed ID: 16271808
[TBL] [Abstract][Full Text] [Related]
6. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
Tang Q; Xiong S; Liang X; Kuai X; Wang Y; Wang C; Feng Z; Zhu J
BMC Infect Dis; 2018 Dec; 18(1):640. PubMed ID: 30526504
[TBL] [Abstract][Full Text] [Related]
10. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
Steiniger SC; Altobell LJ; Zhou B; Janda KD
Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
[TBL] [Abstract][Full Text] [Related]
11. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.
Ribot WJ; Powell BS; Ivins BE; Little SF; Johnson WM; Hoover TA; Norris SL; Adamovicz JJ; Friedlander AM; Andrews GP
Vaccine; 2006 Apr; 24(17):3469-76. PubMed ID: 16519970
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
[TBL] [Abstract][Full Text] [Related]
14. Anthrax capsule vaccine protects against experimental infection.
Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
[TBL] [Abstract][Full Text] [Related]
15. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
Parreiras PM; Sirota LA; Wagner LD; Menzies SL; Arciniega JL
Vaccine; 2009 Jul; 27(33):4537-42. PubMed ID: 19501205
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro].
Belova EV; Dubileĭ SA; Kravchenko TB; Kolesnikov AV; Zakharova MIu; Shemiakin IG
Mol Gen Mikrobiol Virusol; 2004; (3):21-6. PubMed ID: 15354937
[TBL] [Abstract][Full Text] [Related]
18. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
[TBL] [Abstract][Full Text] [Related]
19. In vitro correlate of immunity in a rabbit model of inhalational anthrax.
Pitt ML; Little SF; Ivins BE; Fellows P; Barth J; Hewetson J; Gibbs P; Dertzbaugh M; Friedlander AM
Vaccine; 2001 Sep; 19(32):4768-73. PubMed ID: 11535328
[TBL] [Abstract][Full Text] [Related]
20. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
